# Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

> **NCT04056104** · NA · COMPLETED · sponsor: **University of California, Davis** · enrollment: 543 (actual)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DIAGNOSTIC_TEST:** SpO2 and PIx Measurement

## Key facts

- **NCT ID:** NCT04056104
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-23
- **Primary completion:** 2021-12-12
- **Final completion:** 2021-12-12
- **Target enrollment:** 543 (ACTUAL)
- **Last updated:** 2022-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04056104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04056104, "Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04056104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*